Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
Not Confirmed
Not Confirmed
07-09 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-s-landmark-approvals-of-bms-schizo-med-madrigal-s-mash-drug-us-16-5-bn-catalent-buyout-make-it-to-top-10-news-of-2024
23 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/23/3001118/29248/en/Blarcamesine-Receives-EMA-Filing-Acceptance-for-Treatment-of-Alzheimer-s-Disease.html
23 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/23/3001160/29248/en/Anavex-Life-Sciences-Reports-Fiscal-2024-Fourth-Quarter-Financial-Results-and-Provides-Business-Update.html
09 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/09/2993663/29248/en/Anavex-Life-Sciences-to-Report-New-Long-Term-Oral-Blarcamesine-Phase-IIb-III-Alzheimer-s-Disease-Data-at-J-P-Morgan-2025-Healthcare-Conference.html
26 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/26/2987382/29248/en/Anavex-Life-Sciences-Announces-Submission-of-Blarcamesine-MAA-for-Treatment-of-Alzheimer-s-Disease-to-EMA.html
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2986572/29248/en/Anavex-Life-Sciences-Announces-Acceptance-of-Peer-Reviewed-Manuscript-of-Oral-Blarcamesine-Phase-IIb-III-Data-in-a-Reference-Alzheimer-s-Disease-Journal.html
31 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/31/2972323/29248/en/Anavex-s-Blarcamesine-Achieves-Pre-specified-Efficacy-in-Phase-IIb-III-Alzheimer-s-Trial-Data-Presented-at-CTAD-Conference-2024.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?